Survival analysis of 219 dogs with hyperadrenocorticism attending primary-care practice in England

Schofield, I; Brodbelt, D C; Niessen, S J M; Church, D B; O'Neill, D G

Abstract

Dataset of all 219 dogs included in the study. The study used routinely recorded primary-care clinical data collected within the Veterinary Companion Animal Surveillance System project, VetCompassTM and included all dogs under veterinary care at collaborating practices in England between 1 Jan 2009 and 31 Dec 2013. The end of follow-up for the study was 4 Apr 2018. Available clinical data for the study included the attending veterinary surgeons clinical notes, laboratory results and prescribed treatments recorded within the anonymised electronic patient records (EPRs). The case definition for incident cases of hyperadrenocorticism required the dog to have one of the following: i) a definitive diagnosis of hyperadrenocorticism recorded in the clinical notes; ii) at least one recorded prescription of trilostane, with at least one commonly-used screening test for hyperadrenocorticism recorded (ACTH stimulation test, low dose dexamethasone suppression test (LDDST) or urine cortisol-creatinine ratio (UCCR)). Cases reported as iatrogenic within the EPR were excluded from analysis.

Citation

Schofield, I., Brodbelt, D. C., Niessen, S. J. M., Church, D. B., & O'Neill, D. G. Survival analysis of 219 dogs with hyperadrenocorticism attending primary-care practice in England. [Data]. https://doi.org/10.34840/rzys-dj26

• Deposit Date: Jul 10, 2019
• Publicly Available Date: Nov 20, 2020
• DOI: https://doi.org/10.34840/rzys-dj26
• Public URL: https://rvc-repository.worktribe.com/output/1381865
• Type of Data: Clinical Data